SciSparc Ltd. (NASDAQ:SPRC) Sees Large Decrease in Short Interest

SciSparc Ltd. (NASDAQ:SPRC) was the target of a significant drop in short interest during the month of March. As of March 31st, there was short interest totaling 31,736 shares, a drop of 62.4% from the March 15th total of 84,388 shares. Based on an average trading volume of 15,086 shares, the short-interest ratio is currently 2.1 days. Approximately 8.1% of the company’s shares are sold short.

SciSparc Trading Up 5.2%

SPRC stock traded up $0.16 during midday trading on Tuesday, reaching $3.23. 7,267 shares of the company’s stock traded hands, compared to its average volume of 153,710. SciSparc has a fifty-two week low of $2.98 and a fifty-two week high of $94.50. The business has a 50-day moving average price of $4.64 and a two-hundred day moving average price of $15.92.

About SciSparc

SciSparc AG is a clinical‐stage medical technology company focused on the development and commercialization of extracorporeal shock wave–based neuromodulation devices. Founded in 2016 and headquartered in Switzerland, the company applies proprietary low‐intensity shock wave technology to noninvasively stimulate neural tissue. SciSparc completed its initial public offering on the NASDAQ in 2021 under the ticker SPRC, securing funding to advance its clinical pipeline.

The company’s lead product, the TR100 system, delivers transcranial shock wave stimulation (tSWS) designed to target areas of the brain associated with motor control and cognitive function.